Norway· NO-ID_49BCA51F-0F36-451D-B0D3-27E119E77DC7
Atectura Breezhaler
A indacaterol und mometason product containing mometasone furoate + indacaterol, registered in Norway by Novartis Europharm Limited (1). The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Indacaterol und mometason is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AK14 (indacaterol und mometason), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Indacaterol und mometason · ATC R03AK14
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of indacaterol und mometason costs, country by country.
Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Indacaterol und mometason · price per daily dose (0.15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.85
The record
At a glance
FEST (Norway)- Active substance
- Mometasone Furoate + Indacaterol
- Manufacturer
- Novartis Europharm Limited (1)
- Country
- Norway (NO)
- ATC code
- R03AK14
- ATC class
- Indacaterol und Mometason
- Defined daily dose
- 0.15 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- June 5, 2026
Packs & prices · 3
- no_merkevare_idID_49BCA51F-0F36-451D-B0D3-27E119E77DC7
- no_varenummer152408
- gtin7613421043773
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol und mometason in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATECTURA BREEZHALERNovartis Europharm Limited, Dublin
- SpainATECTURA BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)Novartis Europharm Limited
- SwedenAtectura Breezhaler 125 mikrogram/127,5 mikrogram Inhalationspulver, hård kapselNovartis Europharm Limited
- PolandAtectura BreezhalerNovartis Europharm Limited
- FinlandAtectura BreezhalerNovartis Europharm Limited
- SwitzerlandAtectura Breezhaler
- IcelandAtectura BreezhalerNovartis Europharm Limited*
- IrelandAtectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Atectura Breezhaler, Bemrist Breezhaler
- Liechtenstein · Atectura Breezhaler, Bemrist Breezhaler
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/408cca61-8e8b-4e8a-92fd-f79cd9cf830b GET /v1/drugs/408cca61-8e8b-4e8a-92fd-f79cd9cf830b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalasjonspulver, hard kapsel",
"source": "fest",
"status": "A",
"atc_name": "Indakaterol og mometason",
"merkevare_id": "ID_49BCA51F-0F36-451D-B0D3-27E119E77DC7",
"name_form_strength": "Atectura Breezhaler inh pulv, kaps 125 mikrog/260 mikrog",
"prescription_group": "C"
}See everything about indacaterol und mometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.